Commercial molecular tests for human papillomaviruses (HPV) are invaluable diagnostic
tools in cervical carcinoma screening and management of women with cervical …

Highlights•Human papillomavirus (HPV) has a primordial role in the development of cervical
cancer.•Therapies currently available for cervical cancer treatment are reviewed.•The …

Viral infections contribute 15–20 percent of all human cancers as a cause. Oncogenic virus
infection may spur various stages of carcinogenesis. For several forms for HPV, about 15 …

Human Papillomavirus (HPV) is the causative agent in the majority of anal, head and neck,
oral, oropharyngeal, penile, vaginal, vulvar, and cervical cancers. Cervical cancer is the …

In this work, fluorogenic probes based on oligonucleotide capped nanoporous anodic
alumina films are developed for specific and sensitive detection of human papilloma virus …

Cervical cancer prevention is based on primary prevention with vaccines against Human
Papillomavirus (HPV) and secondary prevention by screening with High‐Risk‐HPV (Hr …

This study explored the knowledge, attitude, practice and barriers to prescribe human
papillomavirus (HPV) vaccines among private primary care physicians in Hong Kong. A self …

Abstract High-Risk Human papillomavirus (HR-HPV) full genotyping methods have been
described as of great potential use in epidemiology and preventive strategies, including …

Background and objectives The precise grading and characterization of cervical
intraepithelial neoplasia (CIN) has been the focus of pathologists for a long time. This study …

El cáncer cérvico-uterino (CCU), que está fuertemente asociado a la infección por virus
papiloma humano de alto riesgo (VPH-AR), sigue siendo un problema de salud pública en …